NCT00001533View on ClinicalTrials.gov

Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

September 30, 1996

Study Completion Date

September 30, 2000

Conditions
AnemiaLeukemia, T-CellLymphocytosisNeutropeniaThrombocytopenia
Interventions
DRUG

cyclosporine

Trial Locations (1)

20892

National Heart, Lung and Blood Institute (NHLBI), Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00001533 - Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine | Biotech Hunter | Biotech Hunter